Get the full picture
Sign in to uncover key details.
KY
Vice President, Technical Operations & Qualit...
Get the full picture
Sign in to uncover key details.
Solstice Oncology
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Berkeley St Ste 18, Boston, Massachu...Website
www.solsticeoncology.comRevenue
<$5 MillionIndustry
About Solstice Oncology
Solstice Oncology is a clinical-stage immuno-oncology company built around the neoadjuvant treatment setting, the point in a patient's disease course where the company believes the opportunity to improve cure rates and long-term survival is greatest. Founded in February 2026, Solstice is led by a team with decades of experience building and advancing successful immunotherapy drugs in oncology. The company is advancing porustobart, a second-generation, Fc-enhanced CTLA-4 antibody, across two clinical indications: a Phase 2 study in combination with pembrolizumab in the neoadjuvant setting for clinical stage II-III MSS colon cancer, and a second, undisclosed clinical indication.Explore more
Solstice Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Frequently Asked Questions Regarding Solstice Oncology
Sign Up For FreeTo access detailed company insights
Solstice Oncology is a clinical-stage immuno-oncology company built around the neoadjuvant treatment setting, the point in a patient's disease course where the company believes the opportunity to improve cure rates and long-term survival is greatest. Founded in February 2026, Solstice is led by a team with decades of experience building and advanci... Read More
